ASP Isotopes

ASP Isotopes Inc. is a leader in isotope enrichment technology, serving the medical, semiconductor, and nuclear energy sectors. Founded in 2021, the company builds on over 20 years of research and development, with roots tracing back to South Africa's uranium enrichment program in the 1980s. ASP Isotopes is publicly traded on NASDAQ under the ticker symbol ASPI. The company specializes in producing enriched isotopes using two proprietary technologies: the Aerodynamic Separation Process (ASP) and Quantum Enrichment (QE). These methods allow for the efficient separation of isotopes for various applications. ASP Isotopes produces stable isotopes and short half-life radioisotopes for medical uses, enriches isotopes for the semiconductor industry, and develops nuclear fuels through its subsidiary, Quantum Leap Energy LLC. The company has also expanded its operations with a majority stake in PET Labs, a leader in nuclear medicine services in South Africa.